Respiratory Viral Infections in Lung Transplantation
Speaker: Cynthia Fisher, MD, MPH • University of Washington
Moderator: Sangeeta Bhorade, MD • Northwestern University
After participating in this webinar, the learner will be able to:
- Describe the incidence and clinical impact of respiratory viruses (RVs) in lung transplant recipients (LTR).
- Explain the evidence linking RVI to chronic lung allograft dysfunction (CLAD).
- List currently available and promising investigational therapies for: RSV, Influenza, and PIV.
- Discuss prevention strategies.
Donate
Donate
Career Center
Career Center
Patient Education
Patient Education
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.